Skip to main content
Log in

Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease

  • Original Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Previous studies reporting long-term (≥5 year) clinical outcome in patients with unprotected left main coronary artery (LMCA) disease undergoing drug-eluting stent (DES) implantation are currently limited, although late adverse events beyond 1 year are one of the major concerns of DES. We evaluated long-term clinical outcomes in 134 consecutive patients who underwent sirolimus-eluting stents (SES) for unprotected LMCA lesion in a single center from 2004 to 2009. The median follow-up duration was 3.8 (range: 0.5–7.9) years. Eight patients suffered from serious cardiovascular events potentially related to LMCA lesion (primary outcome measure) (sudden cardiac death: N = 5, emergent coronary revascularization for the LMCA lesion: N = 2, and acute congestive heart failure related to LMCA lesion: N = 1) with the cumulative 5-year incidence of only 4.4 %. The cumulative 5-year incidence of all-cause death, cardiac death, target vessel myocardial infarction, definite stent thrombosis, and target-lesion revascularization was 26.5, 8.1, 0, 0, and 12.9 %, respectively. In a subgroup analysis, the cumulative incidence of the primary outcome measure was significantly higher in patients with 2-stenting (N = 27) than in patients with 1-stenting (N = 107) (14.0 and 2.2 %, P < 0.001). All 8 patients with serious adverse events had a true bifurcation lesion and 5 patients received 2-stenting for the LMCA lesion. SES implantation in patients with unprotected LMCA lesion was associated with a favorable long-term outcome with acceptably low rate of serious adverse event potentially related to LMCA lesion. However, complex LMCA lesions necessitating 2-stenting strategy might be associated with higher risk for serious adverse events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Seung KB, Park D-W, Kim Y-H, Lee S-W, Lee CW, Hong M, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med. 2008;358:1781–92.

    Article  CAS  PubMed  Google Scholar 

  2. Black A, Cortina R, Bossi I, Choussat R, Fajadet J, Marco J. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol. 2001;37:832–8.

    Article  CAS  PubMed  Google Scholar 

  3. Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Ueda H, Kawai K, et al. Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher registry. Circulation. 2009;120:1866–74.

    Article  PubMed  Google Scholar 

  4. Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, et al. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). Am J Cardiol. 2010;106:329–36.

    Article  PubMed  Google Scholar 

  5. Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation. 2007;116:158–62.

    Article  CAS  PubMed  Google Scholar 

  6. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation. 2005;111:791–5.

    Article  CAS  PubMed  Google Scholar 

  7. Tan WA, Tamai H, Park SJ, Plokker HWW, Nobuyoshi M, Suzuki T, et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation. 2001;104:1609–14.

    Article  CAS  PubMed  Google Scholar 

  8. Park S-J, Kim Y-H, Lee B-K, Lee S-W, Lee CW, Hong M, et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol. 2005;45:351–6.

    Article  CAS  PubMed  Google Scholar 

  9. Park SJ, Hong MK, Lee CW, Kim JJ, Song JK, Kang DH, et al. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol. 2001;38:1054–60.

    Article  CAS  PubMed  Google Scholar 

  10. Silvestri M, Barragan P, Sainsous J, Bayet G, Simeoni JB, Roquebert PO, et al. Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol. 2000;35:1543–50.

    Article  CAS  PubMed  Google Scholar 

  11. Morice M-C, Serruys PW, Kappetein a P, Feldman TE, Ståhle E, Colombo A. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121:2645–53.

    Article  CAS  PubMed  Google Scholar 

  12. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl J a, Cercek B, et al. ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation. 2011;2011(124):e574–651.

    Google Scholar 

  13. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation. 2012;125:584–91.

    Article  CAS  PubMed  Google Scholar 

  14. Chieffo A, Magni V, Latib A, Maisano F, Ielasi A, Montorfano M. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience. JACC Cardiovasc Interv. 2010;3:595–601.

    Article  PubMed  Google Scholar 

  15. Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Nishikawa H, et al. Comparison of 5-Year Outcomes in Patients With and Without Unprotected Left Main Coronary Artery Disease After Treatment With Sirolimus-Eluting Stents: insights From the j-Cypher Registry. JACC Cardiovasc Interv. 2013;6:654–63.

    Article  PubMed  Google Scholar 

  16. Pei HJ, Sui YG, Wu YJ, Yang YJ, Xu B, Chen JL, et al. Long-term clinical outcomes of patients with unprotected left main bifurcation lesions treated with 2-stent techniques. Chin Med J. 2013;126:2409–13.

    PubMed  Google Scholar 

  17. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol. 2008;51:2212–9.

    Article  CAS  PubMed  Google Scholar 

  18. Girasis C, Farooq V, Diletti R, Muramatsu T, Bourantas CV, Onuma Y, et al. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery). JACC Cardiovasc Interv. 2013;6:1250–60.

    Article  PubMed  Google Scholar 

  19. Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011;57:538–45.

    Article  PubMed  Google Scholar 

  20. Park D-W, Seung KB, Kim Y-H, Lee J-Y, Kim W-J, Kang S-J, et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry. J Am Coll Cardiol. 2010;56:117–24.

    Article  PubMed  Google Scholar 

  21. Shiomi H, Tamura T, Niki S, Tada T, Tazaki J, Toma M, et al. Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with taxus and cardiac surgery (syntax) score and association of the syntax score with clinical outcome in patients undergoing unprotected left. Circ J. 2011;75:1130–7.

    Article  PubMed  Google Scholar 

  22. Serruys PW, Unger F, van Hout BA, van den Brand MJ, van Herwerden LA, van Es GA, et al. The ARTS study (arterial revascularization therapies study). Semin Interv Cardiol. 1999;4:209–19.

    CAS  PubMed  Google Scholar 

  23. Takagi T, Stankovic G, Finci L, Toutouzas K, Chieffo A, Spanos V, et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation. 2002;106:698–702.

    Article  PubMed  Google Scholar 

  24. Park S-J, Park S, Hong M-K i, Lee CW, Lee J-H, Kim J–J. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardiol. 2003;91:12–6.

    Article  PubMed  Google Scholar 

  25. Yamaji K, Kimura T, Morimoto T, Nakagawa Y, Inoue K, Soga Y, et al. Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation. Circ. Cardiovasc. Interv. 2010;3:468–75.

    Article  PubMed  Google Scholar 

  26. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kimura T, et al. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term(5-7 years) follow-up of the CREDO-Kyoto Registry Cohort-2. Circ. Cardiovasc Interv. 2014; in-press.

  27. Serruys PW, Morice M-C, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–72.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank paramedical assistants of catheterization laboratory in Kyoto University Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroki Shiomi.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 78 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Higami, H., Shiomi, H., Niki, S. et al. Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease. Cardiovasc Interv and Ther 30, 189–197 (2015). https://doi.org/10.1007/s12928-014-0297-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-014-0297-x

Keywords

Navigation